Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 89
Titolo Data di pubblicazione Autore(i) File
Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole blood model 2010 Serpe L; Canaparo R; Daperno M; Sostegni R; Martinasso G; Muntoni E; Ippolito L; Vivenza N; Pera A; Eandi M; Gasco MR; Zara GP
Solid lipid nanoparticles and microemulsions for drug delivery The CNS. 2009 M. R. Gasco;L. Priano; G. P. Zara
Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug 2008 Brioschi, Andrea*; Zara, Gian Paolo; Calderoni, Sara; Gasco, Maria Rosa; Mauro, Alessandro
Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors? 2007 A. BRIOSCHI; F. ZENGA; GP. ZARA; MR. GASCO; A. DUCATI; A. MAURO
In vitro effects of anti-inflammatory drugs incorporated in Solid Lipid Nanoparticles on human peripheral mononuclear blood cells from IBD patients 2007 Serpe L; Canaparo R; Daperno M; Eandi M; Gasco MR; Zara GP
In vitro effects of anti-inflammatory drugs incorporated in Solid Lipid Nanoparticles on human peripheral mononuclear blood cells from IBD patients 2007 Serpe L; Canaparo R; Daperno M; Eandi M; Gasco MR; Zara GP
Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines 2006 SERPE L; GUIDO M; CANAPARO R; MUNTONI E; CAVALLI R; PANZANELLI P; DELLA PEPA C; BARGONI A; MAURO A; GASCO MR; EANDI M; ZARA GP
Ophthalmic delivery of dexamethsone and tobramycin incorporated in solid lipid nanoparticles 2005 Zara GP; Cavalli R; Canaparo R; Serpe L; Muntoni E; Gasco MR; Eandi M
Ophthalmic delivery of dexamethasone and tobramycin incorporated in solid lipid nanoparticles 2005 Zara GP; Cavalli R; Canaparo R; Serpe L; Muntoni E; Gasco MR; Eandi M
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines 2005 Serpe L; Cavalli R; Canaparo R; Muntoni E; Gasco MR; Eandi M; Zara GP
Preparazioni semisolide 2004 Gasco M.R.; Carlotti M.E.; Gallarate M.; Ugazio E.
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 2004 SERPE L; LAURORA S; PIZZIMENTI S; UGAZIO E; PONTI R; CANAPARO R; BRIATORE F; BARRERA G; GASCO MR; BERNENGO MG; EANDI M; ZARA GP
Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line 2004 SERPE L; CATALANO MG; CAVALLI R; UGAZIO E; BOSCO O; CANAPARO R; MUNTONI E; FRAIRIA R; GASCO MR; EANDI M; ZARA GP
IN VITRO AND IN VIVO STUDY OF SOLID LIPID NANOPARTICLES LOADED WITH SUPERPARAMAGNETIC IRON OXIDE 2003 E. PEIRA; MARZOLA P; PODIO V; AIME S; SBARBATI A; GASCO M.R
Cytotoxicity of solid lipid nanoparticles incorporating butyric acid and doxorubicin on a human colorectal cancer cell line 2003 Serpe L; Catalano MG; Cavalli R; Ugazio E; Muntoni E; Canaparo R; Muntoni E; Frairia R; Gasco MR; Zara GP; Eandi M
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin 2003 R. CAVALLI; A. BARGONI; V. PODIO; E. MUNTONI; G.P. ZARA; M.R. GASCO
Scale-Up and optimization of an evaporative drying process applied to aqueous dispersions of Solid Lipid Nanoparticles 2003 E. MARENGO; R. CAVALLI; G. ROVERO; M.R. GASCO
Evaluation of antiproliferative activity of cholesteryl butyrate solid lipid nanospheres on leukemic cell lines 2002 Serpe L; Laurora S; Pizzimenti S; Ugazio E; Ponti R; Barrera G; Gasco MR; Zara GP; Eandi M
Pharmacokinetic and biodistribution of idarubicin incorporated in solid lipid nanoparticles 2002 G.P. ZARA; A. BARGONI; R. CAVALLI; M.R. GASCO; M.EANDI
THE EFFECT OF FORMULATION AND CONCENTRATION OF CHOLESTERYL BUTYRATE SOLID LIPID NANOSPHERES (SLN) ON NIH-H460 CELL PROLIFERATION 2001 UGAZIO E; MARENGO E; PELLIZZARO C; CORADINI D; E. PEIRA; DAIDONE M.G; GASCO M.R
Mostrati risultati da 1 a 20 di 89
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile